WestEnd Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
WestEnd Advisors's MRNA Position: Q3 2026 in Review
WestEnd Advisors held its Moderna (MRNA) position steady in Q3 2026 at 31 shares worth $5.97K. The position accounts for ﹤0.01% of the portfolio, ranked #130.
WestEnd Advisors first reported a position in MRNA in Q4 2021 and has held it in 17 quarters since. 1,053 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- WestEnd Advisors held 31 shares of Moderna worth $5.97K as of Q3 2026.
- WestEnd Advisors left its Moderna share count unchanged in Q3 2026.
- Moderna made up ﹤0.01% of WestEnd Advisors's portfolio in Q3 2026, its #130 holding.
- WestEnd Advisors first reported a position in Moderna in Q4 2021 and has held it in 17 quarters since.
- 1,053 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on WestEnd Advisors's 13F filing for Q3 2026, filed 27 Oct 2026.